The Serum Institute of India will begin the phase II / III human clinical trials of the Oxford novel coronavirus disease (COVID-19) vaccine candidate, Covishield, August 25, 2020. The trials — observer-blind, randomised and controlled — will begin at the Bharati Vidyapeeth Medical College and Hospital in Pune.